Human -defensins (hBDs) are host defense peptides that not only exhibit microbicidal properties but also stimulate various cellular activities, including keratinocyte proliferation, migration and wound healing. hBDs are overexpressed in the skin in cases of psoriasis but are down-regulated in AD skin, although both diseases are associated with stratum corneum barrier defects. Because the tight junction (TJ) barrier is dysfunctional in both AD and psoriasis patients, we hypothesized that hBDs may regulate the TJ barrier function in keratinocytes. We observed that among the hBDs tested, only hBD-3 increased the expression of several claudins and their localization along the cell-cell borders. Additionally, hBD-3 elevated the transepithelial electrical resistance and reduced the paracellular permeability of keratinocyte layers, and this effect was reversed by the claudin inhibitor ochratoxin A, CCR6 antibody and CCR6 siRNA. Moreover, hBD-3 enhanced the activation of Rac1, atypical PKC, glycogen synthase kinase-3 and PI3K, which are required for the hBD-3-mediated regulation of the TJ barrier function, as evidenced by the effects of their respective inhibitors. Collectively, our findings provide evidence regarding the contribution of host defense peptides to the innate immunity of skin by regulating TJ barrier function, in addition to their antimicrobial and other immunomodulatory activities.
Introduction
The skin upholds homeostasis by preventing water loss via evaporation and precluding the penetration of exogenous substances due to its structural integrity and secretion of complement proteins and cytokines/chemokines (Baroni et al., 2012) . As an antimicrobial barrier, the skin generates a number of antimicrobial or host defense peptides (HDPs). Besides their antimicrobial activities, HDPs exhibit a wide variety of immunomodulatory functions, including promoting chemotaxis, stimulating chemokine/cytokine production, suppressing pro-inflammatory responses, and inducing cell proliferation, angiogenesis and wound healing (Niyonsaba et al., 2006; Niyonsaba et al., 2009) .
The major HDPs found in human skin include the human -defensins (hBDs) and LL-37. The hBDs are characterized by the presence of three family-specific disulfide bonds and are produced mainly by the epithelia of several organs, including the skin (Ganz, 2003; Niyonsaba et al., 2006) . Four hBDs, hBD-1 through hBD-4, have been identified in human skin to date. hBD-1 is constitutively expressed by various epithelial tissues, particularly in the skin, urogenital and respiratory tissues (Ali et al., 2001; Fulton et al., 1997) . hBD-2 was initially identified in psoriatic lesions and was later found in keratinocytes (Harder et al., 1997; Liu et al., 2002) . hBD-3 was first isolated from lesional scales, and although it is a psoriatic product, it is also abundant in non-epithelial tissues (Harder et al., 2001) . Finally, hBD-4 has been identified in the skin only at the mRNA level (Garcia et al., 2001) and is inducible in differentiated keratinocytes (Harder et al., 2004) . In the skin, hBDs have been reported to induce keratinocyte migration, proliferation and cytokine/chemokine production and to accelerate wound healing (Niyonsaba et al., 2005; Niyonsaba et al., 2007; Sorensen et al., 2003) . Skin-derived HDPs are closely associated with skin diseases. For instance, the expression of hBDs and LL-37 is up-regulated in cases of wounding, acne vulgaris, and psoriasis (Niyonsaba et al., 2005; Niyonsaba et al., 2007; Sorensen et al., 2003) ; on the contrary, their expression is down-regulated in AD (Nomura et al., 2003; Ong et al., 2002) . 4 This finding explains why patients with AD but not psoriasis often demonstrate increased susceptibility to infections.
It was recently demonstrated that uninvolved AD skin, in contrast to psoriatic skin, has a markedly reduced content of tight junction (TJ) proteins, resulting in barrier dysfunction and immune dysregulation in AD patients (De Benedetto et al., 2011) . TJs are cell-cell junctions that form the major barrier controlling the paracellular permeability of water, ions, and solutes across epithelial cell sheets (Kirschner et al., 2013) . TJs mainly consist of claudins, occludin, junctional adhesion molecules, and the zonula occludens (Niessen, 2007) . Claudins are essential for the regulation of TJ function either by enhancing the barrier, e.g., claudin-1, which is crucial for tightening the epithelial barrier (Furuse et al., 2002) or disrupting the barrier, e.g., claudin-2, which attenuates the tightness of the epithelial barrier (Furuse et al., 2001) . Although both psoriasis and AD are associated with an impaired stratum corneum barrier, the TJ protein expression is down-regulated in AD (De Benedetto et al., 2011) but normal, increased or decreased in psoriasis (Itoh et al., 2005; Kirschner et al., 2009; Peltonen et al., 2007) . Because the expression of hBDs is reduced in AD but increased in psoriasis, our objective was to investigate the effects of hBDs on the TJ barrier function in skin and to examine the possible underlying mechanisms of the effects.
Here, we demonstrated that hBD-3 enhanced the expression and cell membrane localization of certain claudins and elevated transepithelial electrical resistance (TER) while reducing paracellular permeability in keratinocyte layers, through CCR6 signaling. Additionally, hBD-3 activated the Rac1, atypical PKC (aPKC), glycogen synthase kinase (GSK)-3, and phosphatidylinositol 3 kinase (PI3K) pathways, which are necessary for the hBD-3-mediated regulation of the TJ barrier function.
These observations provide evidence of the contribution of HDPs to the innate immunity of the skin through regulating the TJ barrier function.
Results

hBD-3 increases the expression and membrane localization of TJ proteins
Among the four hBDs, only hBD-3 significantly and dose-dependently up-regulated (from 4-to 60-fold) the expression of claudin-1 through . In contrast, hBD-3 did not affect the expression of occludin, cadherin and zonula occludens (data not shown), suggesting that it is a selective effector. Unexpectedly, hBD-1, -2 and -4, even at doses as high as 40 g/ml, did not increase the expression of the TJ proteins tested (data not shown). Western blot analysis revealed that only claudin-1, claudin-3, claudin-4, claudin-14 and claudin-23 were enhanced at the protein level following hBD-3 stimulation ( Fig. 1b ). Because the cellular localization of TJ proteins is essential for functional TJ formation, the effect of hBD-3 on cellular distribution of claudins was examined. hBD-3 induced a widespread localization of claudin-1, claudin-3, claudin-4 and claudin-14, and a slight increase of claudin-23 at the cell-cell borders (Fig. 2) . Thus, the selective effect of hBD-3 on certain claudins implies the importance of these molecules in the hBD-3-mediated regulation of TJ barrier function.
Ochratoxin A blocks hBD-3-mediated changes in the TJ barrier function
To examine whether the hBD-3-mediated changes in claudin localization were associated with the TJ function, we assessed the TJ barrier function parameters, TER and paracellular permeability of FITC-dextran (Matter and Balda, 2003; Yuki et al., 2007) . Upon stimulation with hBD-3, the TER of keratinocyte layers dose-and time-dependently increased. The highest TER value was observed at 72 h, and it then gradually declined ( Fig. 3a ). Furthermore, as shown in Fig. 3b , control keratinocyte layers exposed to the vehicle exhibited high levels of 4 kDa FITC-dextran flux from the apical compartment to the basolateral compartment. However, the paracellular flux of FITC-dextran through layers treated with hBD-3 was significantly decreased. Paracellular flux 6 following a 72-h treatment was maximally inhibited, and it then progressively increased. This indicates that hBD-3 improves the formation and function of the TJ barrier. Interestingly, hBD-1, hBD-2 and hBD-4 neither markedly affected the membrane localization of claudins ( Fig. S1 ), nor increased TJ barrier function as assessed by TER and paracellular flux ( Fig. S2 ).
Because ochratoxin A is able to induce a decrease in the TJ barrier function by removing claudins (Lambert et al., 2007; McLaughlin et al., 2004) , keratinocyte layers were treated with ochratoxin A, and the TER and paracellular flux were assessed. Ochratoxin A treatment caused a reduced TER and elevated flux of FITC-dextran in hBD-3-stimulated keratinocyte layers ( Fig. 3c ).
This suggests an association between hBD-3-mediated TJ barrier function and reduced expression of claudins.
hBD-3-induced improvement of TJ barrier function is mediated through CCR6
Because hBD-3 functions through CCR6 activation (Nagaoka et al., 2008; Wu et al., 2003) , we tested involvement of CCR6 in the hBD-3-mediated regulation of TJ function by treating keratinocyte layers with CCR6 neutralizing Ab or transfecting cells with CCR6 siRNA to knockdown CCR6 receptor ( Fig. S3 ). As pictured in Fig. 4a and 4b, both CCR6 neutralizing Ab and CCR6 siRNA markedly reduced TER and increased the paracellular permeability to the baseline in hBD-3-stimulated layers, demonstrating involvement of CCR6 in hBD-3-mediated improvement of TJ barrier function.
hBD-3 induces activation of aPKC and Rac1, which are necessary for the TJ barrier function
The aPKC family has two isoforms, aPKC and aPKC/, which are expressed in keratinocytes and are associated with TJ proteins (Helfrich et al., 2007) . Thus, we investigated the possible role of these kinases in hBD-3-mediated regulation of TJ barrier function. We observed that the phosphorylation of aPKC/ was markedly enhanced in keratinocytes stimulated with hBD-3 for 8 h (Fig. 5a ). This activation was necessary for the hBD-3-improved TJ barrier function, because treatment of keratinocyte layers with GF 109203X, a pan-PKC inhibitor that hampers increases in the TER (Turner et al., 1999) , notably suppressed hBD-3-induced elevation of the TER and also increased the flux of FITC-dextran ( Fig. 5b ).
Furthermore, since aPKC signaling is activated by GTP-bound Rac1-induced protein phosphorylation (Chen and Macara, 2005) and because dominant-negative Rac1 and kinase-dead aPKC inhibit TJ functions (Helfrich et al., 2007; Mertens et al., 2005) , we investigated whether hBD-3 regulates TJ barrier function by activating GTP-Rac1. First, Rac1 pull-down assays revealed that hBD-3 stimulation increased the level of activated GTP-Rac1, compared to that of control samples, in as little as 5 min, and this effect was sustained for up to 15 min ( Fig. 5c ). GTP-Rac1 is indeed required for the TJ barrier function because blockade of Rac1 activation using NSC23766 (Baumer et al., 2009) , resulted in reduced TER and enhanced paracellular flux of FITC-dextran in hBD-3-stimulated keratinocyte layers ( Fig. 5d ).
hBD-3 regulates TJ barrier function through activating GSK-3 and PI3K
GSK-3 is implicated in the expression of TJ proteins and the maintenance of the TJ barrier function (Doble and Woodgett, 2003) . We therefore hypothesized that hBD-3 might also activate GSK-3 to regulate the TJ barrier function. The results revealed a strong GSK-3/ (Y279/Y216) signal following a 2-h stimulation with hBD-3, and GSK-3 activation was sustained for up to 8 h ( Fig. 6a ). This activation was required for the hBD-3-mediated regulation of the TJ barrier function, as confirmed by the effect of GSK-3 inhibitor, SB 415286 (Severson et al., 2010) , that drastically decreased TER, while markedly increasing the paracellular flux ( Fig. 6b ) in hBD-3-stimulated keratinocyte layers.
Moreover, because PI3K pathway participates in sealing the TJ by improving the TER and TJ protein expression (Gonzalez-Mariscal et al., 2008) , we envisaged that hBD-3 might also mediate 8 PI3K activation. Fig. 6c shows that during stimulation with hBD-3, the PI3K (p85/p55) signal was strongly increased at 0.5 h and then gradually decreased. Treatment of keratinocyte layers with wortmannin disrupted the hBD-3-mediated improvement of the barrier function, as demonstrated by the reduced TER and increased paracellular flux (Fig. 6d) , implying that hBD-3 regulates paracellular permeability through activating PI3K. 9
Discussion
A recent report that impaired TJ protein expression contributes to the barrier dysfunction in AD (De Benedetto et al., 2011) , in contrast to psoriasis, in which the expression of TJ proteins is normal, increased or decreased (Itoh et al., 2005; Kirschner et al., 2009; Peltonen et al., 2007) incited us to hypothesize that the differential expression of hBDs in psoriasis and AD may play a key role in regulating the TJ barrier function. We demonstrated that hBD-3 selectively increased the expression and membrane localization of certain claudins, enhanced the TER, and reduced paracellular flux in keratinocyte layers. This enhancement of the TJ barrier function was controlled by CCR6, aPKC, GTP-Rac1, GSK-3, and PI3K pathways.
The claudin family provides the most important components of TJs, with more than 24 members that determine TJ resistance and permeability (Van Itallie and Anderson, 2006) . We showed that hBD-3 increased the gene expression of claudins, which have been found in keratinocytes (Brandner, 2009; Brandner et al., 2002; De Benedetto et al., 2011; Watson et al., 2007) , and demonstrated that keratinocytes also express claudin-20 and claudin-25. Among these claudins, only claudin-1, claudin-3, claudin-4, claudin-14 and claudin-23 were selectively enhanced at the protein level, and their localization at cell-cell borders was also increased, suggesting the importance of these claudins in the TJ barrier function. Our results corroborate previous findings that claudin-1, claudin-4 and claudin-14 improve TJ function (Anderson and Van Itallie, 2009) , and that claudin-3 and claudin-23 also play a crucial role in TJ regulation (De Benedetto et al., 2011; Milatz et al., 2010; Wolburg et al., 2003) . In contrast, hBD-3 had no effect on the protein expression of claudin-2, claudin-6 and claudin-10 (data not shown), which disrupt the TJ barrier function (Anderson and Van Itallie, 2009; Turksen and Troy, 2002) . This suggests that hBD-3 contributes to the regulation of the epidermal barrier function. Notably, the physiological function of the hBD-3-induced up-regulation of claudins was confirmed by the increased TER and reduced paracellular flux, and these effects were reversed by a claudin inhibitor.
Besides differential production of HDPs, psoriasis and AD are also characterized by a specific difference in the profile of cytokines/chemokines (Wilsmann-Theis et al., 2008) , which are involved in the TJ regulation. For instance, IL-4, IL-13 and eotaxin that are overexpressed in AD attenuate the TJ barrier function (Capaldo and Nusrat, 2009; Jamaluddin et al., 2009) , implying that dysregulated TJ function in AD might be a result of these cytokines/chemokines. In contrast, IFN- and TNF- that are overexpressed in psoriasis improve the TJ function (Capaldo and Nusrat, 2009 ).
However, because these cytokines also down-regulate the TJ function (Capaldo and Nusrat, 2009 ), there are still discrepancies in the TJ regulation in psoriasis. Our previously unreported finding proposes that dysregulated hBD-3 expression might play a key role in the TJ defect observed in both AD and psoriasis.
Although hBD-1 through hBD-4 activate keratinocytes, we unexpectedly found that only hBD-3 regulates the TJ barrier function. One of the reasonable interpretations for this observation is the possibility that hBD-3 may interact with certain specific proteins in keratinocytes, which other hBDs cannot bind. For instance, although hBDs induce cell migration through CCR2, CCR6, and EGFR (Niyonsaba et al., 2007; Rohrl et al., 2010; Wu et al., 2003) , only hBD-3 but not other hBDs inhibits neutrophil apoptosis via CCR6 (Nagaoka et al., 2008) . This incited us to explore the role of CCR6 in hBD-3-mediated TJ barrier function regulation. Neutralizing and knocking-down CCR6 suppressed hBD-3-induced improvement of TJ barrier function, confirming the requirement of this receptor in hBD-3 regulation of TJ function. However, because hBD-3 is a very strong cationic peptide (with a net charge of +11) compared to other hBDs, one could not exclude the possibility that hBD-3 might also efficiently act upon non-selective membrane receptors to activate keratinocytes, as reported for many cationic peptides (Ferry et al., 2002) .
To further investigate the molecular mechanisms by which hBD-3 increases the TJ barrier function, we focused on aPKC, Rac1, GSK-3 and PI3K that regulate TJ formation (Gonzalez-Mariscal et al., 2008; Helfrich et al., 2007; Mertens et al., 2005; Severson et al., 2010) .
The overexpression of aPKC is sufficient for TJ formation in keratinocytes in which TJ formation is defective, and TJ formation is regulated by the polarity protein complex Par3/Par6/aPKC that functions downstream of Rac1 (Mertens et al., 2005) . Furthermore, low GTP-Rac1 levels and reduced aPKC activity suppress the maturation of TJs (Mertens et al., 2005) , and UVB-irradiation of skin causes the deterioration of TJ functionality, which is accompanied by the down-regulation of GTP-Rac1 and aPKC (Yuki et al., 2011) .
Recently, the activity of GSK-3 has also been implicated in regulating the TJ barrier function.
Although GSK-3 was generally considered a constitutive active enzyme, only regulated by inhibition through its phosphorylation at S21/S9 (Doble and Woodgett, 2003) , recent reports have indicated that phosphorylation of GSK-/ at Y279/Y216 leads to GSK-3 activation (Bhat et al., 2000; Sayas et al., 2002) . Therefore, our findings that hBD-3 increased the phosphorylation of GSK-/ at Y279/Y216 but not S21/S9 (data not shown), and that the inhibition of GSK-3 activity reversed TJ barrier function suggested that hBD-3 improves TJ function through GSK-3 activation. This is consistent with studies showing that inhibiting GSK-/ increases epithelial permeability, and this is attributable to the down-regulation of TJ protein expression (Bachelder et al., 2005; Severson et al., 2010) .
Because of evidence implicating PI3K in TJ assembly, the role of the PI3K signaling pathway in the hBD-3-mediated regulation of the TJ barrier function was studied. Our finding is supported by a study showing the requirement for PI3K in DP2-induced claudin-2 expression in lung alveolar cells (Wang et al., 2011) and a report that the PI3K inhibitors attenuate the TER in response to prostaglandins (Little et al., 2003) . Additionally, since the p85 subunit of PI3K binds to occludin, this further suggests the importance of PI3K in TJ tightening (Nusrat et al., 2000) . However, the activation of the PI3K cascade may also result in opposite effects on the TJ barrier function, as PI3K is implicated in reduced TJ protein expression upon treatment with HIV-1 Tat protein (Andras et al., 2005) or TGF1 (Bakin et al., 2000) . Hence, further studies are needed to fully clarify the role of the PI3K signaling pathway in the TJ barrier function. Although other hBDs did not affect keratinocyte layer permeability, they were able to induce at some extent the activation of aPKC, Rac1, GSK-3 and PI3K (Fig. S4) . It seems that the activation of above pathways by hBD-1, hBD-2 or hBD-4 does not affect the regulation of TJ function, but rather may be involved in other activities such as cell survival, wound healing, migration or differentiation (Calautti et al., 2005; Efimova et al., 2004; Koivisto et al., 2003; Tscharntke et al., 2007) , which activities are regulated by hBDs (Niyonsaba et al., 2009) . Other possible TJ function regulators, including TLRs, PKA and MAPKs were also investigated, but failed to show that hBD-3 regulates the TJ barrier function through these components (data not shown).
Collectively, we demonstrated that hBD-3 enhanced the expression and cellular localization of selective TJ proteins, and regulated the TJ barrier function. Therefore, in addition to their antimicrobial and immunomodulatory functions, we provide previously unreported evidence that HDPs also contribute to the regulation of the skin barrier function.
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Materials and Methods
Reagents
Synthetic hBD-1 through hBD-4 were purchased from the Peptide Institute (Osaka, Japan).
Anti-claudin-1, claudin-3 and claudin-4 Abs were from Invitrogen (Carlsbad, CA), whereas the anti-claudin-14 and claudin-23 Abs were obtained from Abcam (Tokyo, Japan).
Anti-phosphorylated GSK-3/ (Y279/Y216), aPKC/ and PI3K Abs, and GSK-3/, aPKC and PI3K Abs were from Cell Signaling Technology (Beverly, MA). Anti-CCR6 Ab was from R&D Systems (Minneapolis, MN). GF 109203X was purchased from Enzo Life Sciences (Farmingdale, NY) and SB 415286 was from Tocris Bioscience (Bristol, UK), whereas wortmannin and ochratoxin A were obtained from Sigma-Aldrich (St Louis, MO). NSC23766 was purchased from Calbiochem (La Jolla, CA).
Keratinocyte culture and stimulation
Keratinocytes purchased from Kurabo Industries (Osaka, Japan) were cultured in HuMedia-KG2 (Kurabo Industries), as described previously (Niyonsaba et al., 2007) . For total RNA extractions and Western blotting, the keratinocytes were cultured in 12-well plates and incubated with peptides in HuMedia without supplements. For the TER and paracellular flux assays, 0.72 × 10 5 cells were plated in transwells with 0.4-m pores (Millipore, Billerica, MA), and the medium was replaced with high-Ca 2+ (1.35 mM) medium after the cells reached confluence.
Total RNA extraction and qRT-PCR
Total RNA extractions and qRT-PCR were performed as previously described (Niyonsaba et al., 2007) . mRNAs were amplified and quantitated using a StepOne Plus Real time PCR System (Applied Biosystems, Branchburg, NJ), following the manufacturer's instructions. The primer/probe sets used were Applied Biosystems assays-on-demand products. The changes in gene expression are reported as fold-increases relative to those of untreated controls.
Western blot analysis
Keratinocytes were incubated with hBDs for the indicated periods. After stimulation, the cells were lysed in RIPA buffer (Cell Signaling Technology) and equal amounts of lysate proteins were subjected to 12.5% SDS-PAGE. The immunoblots were incubated with appropriate Abs according to the manufacturer's instructions. The membranes were developed using Luminata Forte Western HRP substrate (Millipore, Billerica, MA).
Measurements of TER and paracellular flux
Keratinocytes grown on 0.6-cm 2 transwell filters were transferred into the high-Ca 2+ medium, and hBDs were added. The TER across the keratinocyte layers was measured using a CellZscope (nanoAnalytics, Münster, Germany) for 0-120 h. Keratinocytes were also grown on 0.3-cm 2 transwell filters for the paracellular flux assay, which was performed as described previously (Yuki et al., 2007) , using 4 kDa FITC-dextran (Sigma-Aldrich) as a tracer. Briefly, keratinocyte layers were stimulated with hBDs for 0-120 h, and the medium in the apical and basal compartments was replaced with 250 l of P buffer containing 10 mg/ml of FITC-dextran and 700 l of P buffer, respectively. After 2 h, the medium from the basal compartment was collected and fluorescence was measured using a fluorimeter (Nihon Molecular Devices, Tokyo, Japan). In some of the experiments, the keratinocyte layers were pre-treated with specific inhibitors or Abs, or transfected with CCR6 siRNA (Invitrogen) before stimulation, and the efficacy of knockdown was confirmed by qRT-PCR (Fig. S3 ). Inhibitors used in this study had no cytotoxicity as evaluated by trypan blue exclusion and lactate dehydrogenase activity (data not shown). Following treatment, keratinocyte layers were stimulated, and the TER and paracellular flux assays were performed as above. 
Rac1 activation assay
Keratinocytes grown in 12-well plates were stimulated with hBDs for 1-15 min. The cells were lysed in RIPA buffer supplemented with protease inhibitor cocktail, and Rac1 activation in the lysates was determined using a Rac1 activation assay kit (Cytoskeleton, Denver, CO), according to the manufacturer's recommendations.
Immunofluorescence microscopy
Keratinocytes were cultured on collagen I-coated chamber slides (BD Biosciences, Bedford, MA) before fixation with methanol. Cells were blocked in Protein Block Serum-Free (DakoCytomation, Carpentaria, CA) containing 0.2% Tween-20, after which cells were incubated overnight with the appropriate primary Abs in 1% BSA-PBS containing 0.2% Tween 20, followed by specific secondary Abs coupled to Alexa 594 (Invitrogen). Images were captured using confocal laser scanning microscopy (Carl Zeiss, Jena, Germany).
Statistical analysis
Statistical analysis was performed with an ANOVA using Prism GraphPad software (GraphPad Software, San Diego, CA). P < 0.05 was considered significant. The results are presented as the mean values ± SD. 
Figure Legends
Figure 2. hBD-3 enhances immunolocalization of certain claudins
Keratinocytes grown to confluence on collagen I-coated chamber slides were stimulated with 20 g/ml hBD-3 for 72 h. The cells were then fixed in methanol, processed for immunofluorescence with Abs against claudins overnight, and then visualized using confocal laser scanning microscopy.
The results of one representative experiment of three separate experiments yielding similar results are shown. Scale bar = 10 m. 
Figure 5. hBD-3 enhances the TJ function through activation of aPKC/ and GTP-Rac1
Keratinocytes were incubated with 20 µg/ml hBD-3, and lysates were separated by SDS-PAGE using Abs against phosphorylated aPKCζ/ and aPKC (a), or quantified for GTP-Rac1 using a Rac1 activation assay kit (c). One representative experiment of three separate experiments yielding similar results is shown.
Keratinocyte layers were pre-treated with GF 109203X (b), NSC23766 (d) or 0.1% DMSO for 48 h and stimulated with 20 g/ml hBD-3 for 72 h, and the TER and paracellular flux were determined.
28
The values obtained using stimulated and non-stimulated cells or with the presence and absence of inhibitor were compared. * P < 0.05, ** P < 0.01, *** P < 0.001, n=4. Figure S1. Effects of hBD-1, hBD-2 
and hBD-4 on claudin immunolocalization
Keratinocytes grown to confluence on collagen I-coated chamber slides were stimulated with 40 g/ml hBD-1, hBD-2 and hBD-4 for 72 h. The cells were then fixed in methanol, processed for immunofluorescence with Abs against claudins overnight, and then visualized using confocal laser scanning microscopy. The results of one representative experiment of three separate experiments yielding similar results are shown. Scale bar = 10 m. 
